Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Nov 12, 2024 FORM 8-K
SC 13G/A Nov 4, 2024
S-8 Oct 16, 2024 FORM S-8
SC 13G/A Oct 7, 2024 MS AMENDMENT
4 Sep 5, 2024 OWNERSHIP DOCUMENT
3 Sep 5, 2024 OWNERSHIP DOCUMENT
8-K Sep 5, 2024 FORM 8-K
4 Aug 30, 2024 OWNERSHIP DOCUMENT
4 Aug 19, 2024 OWNERSHIP DOCUMENT
EFFECT Aug 14, 2024
CORRESP Aug 13, 2024
UPLOAD Aug 9, 2024
S-3 Aug 8, 2024 S-3
10-Q Aug 8, 2024 10-Q
8-K Aug 8, 2024 FORM 8-K
EFFECT Jul 22, 2024
ARS Jul 19, 2024 ARS
DEFA14A Jul 19, 2024 DEFA14A
DEF 14A Jul 19, 2024 DEF 14A
SC 13G/A Jul 10, 2024
8-K Jun 13, 2024 FORM 8-K
4 Jun 10, 2024 OWNERSHIP DOCUMENT
144 Jun 7, 2024
8-K Jun 6, 2024 FORM 8-K
8-K Jun 3, 2024 FORM 8-K
← Newer Page 8 of 27 · 669 filings Older →